---
figid: PMC7407942__pharmaceuticals-13-00156-g001
figtitle: Schematic process of the autophagic pathway
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC7407942
filename: pharmaceuticals-13-00156-g001.jpg
figlink: pmc/articles/PMC7407942/figure/pharmaceuticals-13-00156-f001/
number: F1
caption: 'Schematic process of the autophagic pathway. Autophagy consists of the following
  stages: induction, phagophore nucleation, elongation, and completion; fusion to
  lysosome, degradation, and recycling. Receptor tyrosine kinases (EGF (epidermal
  growth factor receptor), PDGF (platelet-derived growth factor receptor), and VEGF
  (vascular endothelial growth factor receptor)) stimulate the RAS/RAS/ERK and PI3K/AKT
  signaling pathways, which traduce signals to activate transcription factors, such
  as transcription factor EB (TFEB), FOXO, P53, and NF-кB, which regulate the expression
  of genes that are key for autophagy induction. Then, the activation of AKT inhibits
  autophagic death by activating the mTORC1 complex, which contains mTOR. During nutrient
  deprivation, AMPK stimulates autophagy by phosphorylation of ULK1 and suppression
  of mTORC1, which inhibits autophagy by inactivating ULK1. Autophagy can also be
  induced by hypoxic conditions through HIF activation. Autophagosome biogenesis starts
  with the formation of an initiation membrane, derived from the endoplasmic reticulum
  (ER) or other cellular membrane sources. Vesicle nucleation requires the activity
  of the PI3K-III/Beclin-1 complex. The completion and expansion of the autophagosome
  requires the Atg5/Atg12/Atg16 and LC3-PE proteins. Mature autophagosome fuses with
  a lysosome to form the autophagosome, which requires the action of proteins, such
  as Rab7, UVRAG, and Lamp 1, 2; finally, p62/SQSTM1 is required for the degradation
  and recycling of the cellular components. Black arrows (↓) indicate activation,
  and black truncated arrows (⊥) indicate inhibition. Blue arrows (↓) indicate the
  process of the autophagic pathway.'
papertitle: Autophagy as a Potential Therapy for Malignant Glioma.
reftext: Angel Escamilla-Ramírez, et al. Pharmaceuticals (Basel). 2020 Jul;13(7):156.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9371405
figid_alias: PMC7407942__F1
figtype: Figure
redirect_from: /figures/PMC7407942__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7407942__pharmaceuticals-13-00156-g001.html
  '@type': Dataset
  description: 'Schematic process of the autophagic pathway. Autophagy consists of
    the following stages: induction, phagophore nucleation, elongation, and completion;
    fusion to lysosome, degradation, and recycling. Receptor tyrosine kinases (EGF
    (epidermal growth factor receptor), PDGF (platelet-derived growth factor receptor),
    and VEGF (vascular endothelial growth factor receptor)) stimulate the RAS/RAS/ERK
    and PI3K/AKT signaling pathways, which traduce signals to activate transcription
    factors, such as transcription factor EB (TFEB), FOXO, P53, and NF-кB, which regulate
    the expression of genes that are key for autophagy induction. Then, the activation
    of AKT inhibits autophagic death by activating the mTORC1 complex, which contains
    mTOR. During nutrient deprivation, AMPK stimulates autophagy by phosphorylation
    of ULK1 and suppression of mTORC1, which inhibits autophagy by inactivating ULK1.
    Autophagy can also be induced by hypoxic conditions through HIF activation. Autophagosome
    biogenesis starts with the formation of an initiation membrane, derived from the
    endoplasmic reticulum (ER) or other cellular membrane sources. Vesicle nucleation
    requires the activity of the PI3K-III/Beclin-1 complex. The completion and expansion
    of the autophagosome requires the Atg5/Atg12/Atg16 and LC3-PE proteins. Mature
    autophagosome fuses with a lysosome to form the autophagosome, which requires
    the action of proteins, such as Rab7, UVRAG, and Lamp 1, 2; finally, p62/SQSTM1
    is required for the degradation and recycling of the cellular components. Black
    arrows (↓) indicate activation, and black truncated arrows (⊥) indicate inhibition.
    Blue arrows (↓) indicate the process of the autophagic pathway.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - egr
  - Egfr
  - Pvr
  - Raf
  - ras
  - Ras64B
  - Ras85D
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Pten
  - Tak1
  - MKP-4
  - p38b
  - rl
  - Akt
  - Erk7
  - Lkb1
  - SNF4Agamma
  - AMPKalpha
  - IKKbeta
  - gig
  - Tsc1
  - Rheb
  - Mitf
  - p53
  - betaTub60D
  - hth
  - foxo
  - Dif
  - dl
  - Rel
  - sima
  - Atg17
  - Crtc
  - Atg1
  - Atg10
  - BNIP3
  - Atg6
  - squ
  - Atg12
  - Atg8a
  - Atg5
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - Atg7
  - Atg4a
  - Atg4b
  - Uvrag
  - Atg14
  - ref(2)P
  - DCTN4-p62
  - Tfb1
  - Nup62
  - Taf6
  - how
  - Vps11
  - dor
  - TNF
  - EGFR
  - PDGFRB
  - PDGFRA
  - KDR
  - FLT1
  - FLT4
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - KRAS
  - HRAS
  - NRAS
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PTEN
  - MAP3K7
  - NR2C2
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - AKT1
  - AKT2
  - AKT3
  - EPHB2
  - STK11
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - EGLN1
  - MDM2
  - IKBKB
  - CAMKK1
  - TSC2
  - TSC1
  - CCL26
  - RHEB
  - RHEBP1
  - TFEB
  - TP53
  - TP63
  - TP73
  - FOXO1
  - FOXO3
  - FOXO4
  - FOXO6
  - NFKB1
  - HIF1A
  - RB1CC1
  - LOXL1
  - MTOR
  - RPTOR
  - ULK1
  - ULK2
  - ATG10
  - BECN1
  - ATG12
  - BNIP3L
  - MAP1LC3A
  - ATG5
  - SESN3
  - ATG7
  - ATG4A
  - ATG4B
  - ATG4C
  - ATG4D
  - UVRAG
  - ATG14
  - GTF2H1
  - SQSTM1
  - KHDRBS1
  - NUP62
  - DCTN4
  - VPS11
  - VPS18
---
